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Abstract – Mycobacterium tuberculosis (Mtb) and Mycobacterium bovis (M. bovis) are the etiological
agents of human and bovine tuberculosis (TB, bTB) respectively, and share genetic identity over 99%
at the whole genome level. Progress has been made towards explaining how mycobacteria and their
infected hosts remain in balance without producing clinical symptoms of disease, a phenomenon
referred to as latency or persistence, which can be mimicked by certain in vitro conditions. Latency/
persistence has mainly been studied using Mtb, where the two-component signalling system, dosRS,
has been assigned an instrumental role, and even constitutes the current basis for development of new
diagnostic methods and treatment addressing this particular stage of TB. M. bovis conserves homolog
genes that in Mtb play a role in human latent TB infection and that, by analogy, would allow it to
enter a persistent state in infected cattle; nevertheless, little attention has been paid to this stage in
bovine hosts. We suggest that many of the advances acquired through the study of Mtb can and
should be taken into consideration by research groups and veterinary professionals dealing with bTB.
The study of the infection in bovines, paying particular attention to deﬁning the molecular and
cellular markers of a M. bovis persistent infection in cattle, presents great opportunities for the
development and trial of new diagnostic tests and vaccines, tools that will surely help in promoting
eradication of bTB in high-burden settings.
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lesions and immune responses, which often
result in colonization and spread to the same
organs, namely lungs and lymphatic tissues
[12, 14, 73, 109]. Like in humans, aerosolized
bacteria are the most common source of infec-
tious organisms in cattle, and the primary site
of natural infection is the respiratory tract [14,
21]. In bTB, airborne infection is considered
the most common route of transmission, and
more than 19% of cattle with bTB shed the
mycobacteria [24, 111], mainly early during
infection [68, 70]. The intermittent nature of
bacilli shedding from infected animals, after a
short initial post-infection period has been doc-
umented [67, 68]. Several studies indicate that
between 8–26% of naturally infected animals
release mycobacteria in clinical samples, but
the precise duration of the secretion period is
unknown [75, 95, 111].
Mycobacterium bovis (M. bovis) is a close
relative of Mycobacterium tuberculosis (Mtb),
and they share genetic identity over 99% at
the whole genome level [34]. Different studies
have supported the fact that although slight dif-
ferences are found in the genome sequence of
MtbandM.bovis,thephysiologyandhostrange
spectrum is different [36, 88]. In recent years,
progress has been made regarding the molecular
basis that might, at least partially, explain how
mycobacteria are able to remain in a persistent
or latent infection in its human host, and it has
also been suggested that this particular stage of
disease exists in cattle, by analogy with human
TB [14, 42, 84, 109]; nevertheless, until now
little attention has been paid to this form of
infection in bovine hosts.
TB produced by M. bovis is an important
human zoonosis associated with consumption
of dairy products contaminated with the bacilli,
and to labour risk (such as direct contact or
droplet transmission) in farms or slaughter-
houses [25, 39, 105, 108]. Close to 35% of
the Latin American and Caribbean countries
have reported the occurrence of TB due to
M. bovis, and a conservative estimate would
be that it causes 2% of the total pulmonary
TB cases and 8% of extrapulmonary TB cases.
Moreover, it is also estimated that 60% of the
human population live in countries where cattle
undergo no control or only limited control for
bTB [20], constituting a potential infectious
source. Ideally, all cattle that give positive read-
ings to diagnostic tests should be killed, as they
may well represent a source of ongoing infec-
tion. However, under ﬁnancial constraints, for
example in developing countries, programs to
combat bTB require a more accurate targeting
of cattle that represent the greatest threat of
spreading infection [85]. We must consider
the inability of current assays to discriminate
between active and a likely latent infection in
cattle, which could make the difference
between sacriﬁcing truly contagious animals
or only suspected ones.
It was recently shown that M. bovis
accounted for 45% of all culture-positive TB
cases in children and 6% of adult cases in
San Diego, California, United States, from
1994 to 2005 [93], whereas in the whole coun-
try, 1.4% of linked cases were identiﬁed as M.
bovis [45]. On the other hand, surpassing a pre-
viously thought host preference [34], Mtb
infected cattle has been reported in countries
with high incidence of bTB [16, 105]. Deﬁning
the proportion as well as the clinical presenta-
tion of infected subjects (active or persistent)
in affected countries is no doubt of enormous
importance, as it is determining the same num-
bers for infected cattle [22].
It is worth noting that, contrary to TB, where
active disease often occurs with clinical signs
and symptoms (fever, weight loss, coughing,
presence of acid-fast bacilli (AFB) in sputa or
other clinical samples), during bTB, M. bovis-
infected cattle do not present two well-deﬁned
clinical (active or latent) phases, nor does the
immune reactivity test used nowadays (tubercu-
lin skin test, TST) has the power to discern
between these two likely states in infected
bovines. Asymptomatic TST+ cattle have been
found infected with either M. bovis or Mtb as
well [105].
Clinically, latency is deﬁned as the persis-
tence of a tuberculous lesion with viable myco-
bacteria in a host without symptoms and has
been demonstrated because of reactivation
(deﬁned as the onset of active disease upon,
e.g., an immunosuppressive event) of appar-
ently healthy people and/or reactivity towards
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tions and absence of AFB in clinical specimens
[30, 35, 53, 54]. In contrast, in the context of
bovines, persistence could perhaps be deﬁned
as the existence of a positive skin or IFN-c test
in cattle in which no lesions can be detected or
when a culture is positive in the absence of
lesions. However, the ﬁrst approach presents
the disadvantage of not directly deﬁning
whether reactivity is due to a present or past
infection, or even because of contact with envi-
ronmental mycobacteria. The latter approach is
simply time consuming and again does not nec-
essarily address which organisms are causing
the infection unless more speciﬁc tests (PCR,
hybridization, speciﬁc immune assays) are
conducted.
Although individuals with latent infection
theoretically do not transmit the disease, in
countries where TB does not have a high inci-
dence, it is estimated that there is a risk of 2–
23% of reactivation of the disease during their
lifetime, thus constituting a signiﬁcant source
of transmission upon reactivation [80]. Reacti-
vation is thought to be derived from many
events that lead to immunosuppression, from
experimental evidence using Mtb infection in
a mouse model [8]. Reactivation of latent tuber-
culosis produced by M. bovis infection has been
documented in people with previous exposure
to unpasteurised dairy products [54]. In addi-
tion, in TB cases associated with human M. bo-
vis infection, the HIV/AIDS pandemic may
lead to a greater susceptibility of people to overt
TB [39], as has been shown with the use of
anti-inﬂammatory treatment [54]. Envisioning
a similar scenario, should persistent/latent bTB
in cattle be present, reactivation could be asso-
ciated with changes in cell-mediated immunity
in tuberculous cattle as well as with viral immu-
nosuppression, metabolic unbalance, corticoste-
roids and postpartum period [32, 82, 84, 102].
Nevertheless, the association of bTB with per-
sistent and immunosuppressive viral diseases,
such as bovine viral diarrhoea and bovine leu-
cosis, has not been described in spite of its
enzootic character in dairy cattle and deserves
further attention.
Considering the scarce evidence demonstrat-
ing that M. bovis produces a latent/persistent
infection in humans, and suggesting it can pro-
duce a similar state in cattle, as well as the few
reports intended to decipher and precisely deﬁn-
ing the existence of a chronic/persistent M. bo-
vis infection state during disease, and its impact
for uncontrolled bTB in several countries, we
present this work, pursuing the following goals:
(1) to present a brief summary of the current
status and advances on tuberculosis persistence
both in bovine and humans, and (2) to suggest
paths to converge such knowledge for the ben-
eﬁt of the diagnosis and treatment efforts
against bTB, for their application in the veteri-
nary ﬁeld.
2. IS M. BOVIS PERSISTENCE AFFECTED
BY IMMUNE RESPONSES IN CATTLE?
In a histopathological setting, bTB spreads
not only from animals with gross lung lesions,
but also from those considered to represent a
latent-like (persistent) infection without visible
(gross) lesions [65, 69, 75, 84], although cau-
tion should be taken considering the arguments
expressed above, for the need of clearly demon-
strating (not suspecting) a latent bTB phase.
Post mortem analysis of samples from cattle
with a positive tuberculin skin test (TST+)
and IFN-c test reactors often correlates with
gross lesions mainly in tracheobronchial, medi-
astinal, and retropharyngeal lymph nodes [76].
The majority of bTB cases occurring as natural
infection are restricted to the lower respiratory
tract, but no cavitation of lungs has been found,
as opposed to some chronic human TB cases
[19, 71, 75, 76, 118], raising exciting questions
as to what is the nature of such differences.
Exhaustive histopathological analyses of lungs
have allowed the identiﬁcation of lesions in
70% of bTB cases without visible lesions in
this organ [65]. However, under low prevalence
conditions, close to 60% of animals with TST+
have no visible lesions, and may thus constitute
a persistently infected population, providing a
good source of material for experimentally
addressing the existence of such state in
cattle.
In order to deﬁne the existence of a particu-
lar infection stage, a proper characterization and
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being proposed for the different stages of gran-
uloma development [76]. These are as follows:
stage I/II early non-necrotic lesions; stage III
infected core surrounded by multiple concentric
layers of macrophages (including epithelioid
and giant cells) and ﬁbrous tissue; and stage
IV central caseous necrosis. It is common to
ﬁnd type IV in combination with type I/II
lesions [57]. Since caseous necrosis and calciﬁ-
cation accompanied by a small number of posi-
tive AFB are common features of granulomas
encountered in natural infections, this can be
detected in animals with no visible or isolated
histopathological lesions, independently of their
TST status or IFN-c responses [57, 69, 70].
Changes in the TST status, histopathological
ﬁndings or cellular markers might prove to be
helpful in estimating what type of infection a
bovine has, either active or persistent, and are
problems that surely deserve further explora-
tion, as long as they can be improved to specif-
ically determine M. bovis presence or any other
mycobacteria as agent of the disease.
At a cellular level, once inside the host,
M. bovis is ingested by macrophages and their
activation aids limitation of or destruction of
infecting mycobacteria [23, 86]. Moreover, dif-
ferences in the antibacterial capacity of bovine
macrophages, depending upon microenviron-
ment and organ-speciﬁc factors or genetic back-
ground, may exist [87]. Experimental data
suggests that an excessive immune response
or a high virulence of the bacilli favour the
pathogenesis of bTB [116, 117]. In susceptible
hosts, the interaction of M. bovis with cells from
the innate and adaptive immune response in the
respiratory tissue and lymph nodes results in
colonization and infection with development
of several-stage lesions leading to the produc-
tion of granulomas [76]. Granulomas represent
the focal expression of the inﬂammatory
response aimed at preventing mycobacterial
growth, thus constituting a means whereby bac-
teria could potentially be directed or primed to
enter a persistent state. During this interaction,
T-cells are among the ﬁrst cells involved in
early granuloma formation [13]. All of the main
T-cell subsets (cd T-cells, CD4+ and CD8+ ab
T-cells) have been shown to be involved in the
anti-mycobacterial immune response in cattle
[85]. There, both CD4+ T-cells and CD8+
T-cells have an important involvement in con-
trolling infected cells [85]. Interestingly,
CD8+ cells may play a deleterious role by con-
tributing to the immunopathology of bTB
[110], while WC1+cd T-cell may contribute
toward the Th1 bias of the immune response in
bTB, although they do not appear to be essential
forthe developmentof delayed-typehypersensi-
tivity (DTH) [49, 50]. Within granulomas, there
is a balance between mycobacterial killing and
survival [99] that results in eradication, contain-
ment (persistence, latency) or progression of
the infection, according to which side of the
immune response is favoured [85, 86].
Within granulomas, the presence of AFB
organisms might suggest these bacteria are in
a replicative, rather than a dormant or persistent
state, based on the lack of AFB staining in Mtb
H37Rv under in vitro latent conditions, induced
by nutrient deprivation [3]. However, we must
point out that there is a lack of data about the
acid-fast staining properties of bacilli assumed
to be genetically impaired to enter a latent state
(i.e. dosRS knock-out, a two component system
involved in Mtb latency, described later),
although it was recently demonstrated that the
AFB phenotype is dependent on cell wall lipid
modiﬁcations, controlled by phoP [115] and
kasB [9]. PhoP was reported to affect expres-
sion of DosR-controlled genes [37], and for
kasB either direct or indirect control by dosRS
has not been demonstrated.
It was recently found that depending on the
cytokine proﬁle (either predominantly Th1- or
Th2-type) cattle experimentally infected with
M. bovis present different degrees of histopa-
thological damage, thus strengthening the criti-
cal role of the immune response in the outcome
of bTB [106]. As a consequence of hormonal
changes, immunosuppression might occur dur-
ing peripartum, diminishing cytokines and anti-
bodies, along with Th2 polarization of immune
response [63], which in persistently infected
cows might promote reactivation. Further stud-
ies have indicated the role of additional factors
in the onset and determining susceptibility to
bTB, such as early production of IL-4 secreted
by Th2 lymphocyte subsets [89, 90], and also
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mycobacterial infections, changes in the
immune balance from a dominant Th1-type
response towards a more prominent Th2
response are associated with disease progres-
sion, B-cell antibody production and anergy
of cell-mediated immune responses [85].
Recent attempts to establish immune proﬁles
associated with M. bovis infection status have
been made in cattle suggesting innate immune
gene repression in PBMC from bTB infected
animals [66]. Despite this attempt, it is clear that
immune phenomena in bTB are highly complex
and hard to characterize in cattle. This outlines
the need of modifying and improving the cur-
rent strategies employed to determine bTB
infection status, perhaps moving towards ﬁnd-
ing and validating speciﬁc molecular markers.
3. MYCOBACTERIAL FACTORS
REQUIRED FOR LATENCY
The molecular mechanisms responsible for
the onset of active or latent TB or reactivation
from latency to active TB are not yet well
understood. We must consider that mycobacte-
ria have a complex life cycle and endure an
ever-changing environment while trying to suc-
cessfully establish and maintain an infection or
even while surviving outside their host waiting
for a new infective process to begin. Neverthe-
less, a factor that very likely contributes to the
continued transmission of TB in humans and
perhaps bovine hosts is the demonstrated capac-
ity of mycobacteria to exist in a dormant, per-
sistent or latent state for extended periods of
time, particularly when under stress [80]. This
often leads to dramatic changes in gene tran-
scription, including those of particular interest
in this review, namely genes related to latency,
dormancy or persistence within a hostile envi-
ronment. These include but are not necessarily
limited to: (1) Hypoxia, (2) Reactive Nitrogen
Species (RNI), (3) Reactive Oxygen Species
(RON), (4) the host immune response (NK
cells, activation of TLR and synthesis of host
defence peptides among others). All these fac-
tors impose a combination of stresses that affect
the pathogen [94, 101]. A function that would
be expected to be up regulated during such
attacks is the antioxidant response. In this
regard, genes putatively involved in defence
against oxidative stress can be found in myco-
bacterial genomes, such as noxR1, noxR3, and
ahpC, which possess high identity with genes
encoding for antioxidant enzymes widely dis-
tributed in prokaryotes. The glbN gene, which
codes for a truncated haemoglobin (trHbN), is
responsible for the nitric oxide (NO) metaboliz-
ing activity observed in mycobacterial station-
ary phase in vitro cultures [74]. Additionally,
other components are required for adaptations
occurring during persistent infection in animal
or cellular models, where the protein a-crystal-
lin (HspX, Rv2031c or Acr) from Mtb is
required during the phase of steady growth
within macrophages [104, 122].
Studies in both Mtb and M. bovis var. BCG
grown under stress with low oxygen tension
have shown that HspX is a protein expressed
during these conditions, and is virtually the ﬁrst
protein required for a latency-like state func-
tionally demonstrated to have an impact in both
organisms under these particular conditions [33,
58, 103].
Different studies have approached the ques-
tion of latency using alternative techniques. For
example, Rustad et al. [97] suggest an extended
hypoxic response regulon, and their study
requires in vivo validation of the participation
from genes found in their work. Saxena et al.
[100]usedageneticscreenforinvivoexpressed
technology;however,itishardtodirectlyextrap-
olate studies where not only transcription of
hypoxia-responsive genes is assessed, but also
translational effects (such as altered protein sta-
bilityofGFPand/orkanamycin)likelyoccurring
on the reporter genes should be considered.
Furthermore, the roles of MprAB [77], as
well as PhoP [37] recently added another level
of complexity solely to DosR regulation, and
are not developed in this work in the idea of
suggesting markers to deﬁne whether or not
latency occurs in cattle, conversely to deﬁning
the mechanisms regulating an event that it is
still unclear in bovines. Considering these argu-
ments as well as the evidences linking in vitro
to in vivo relevance for DosR and DosR-regu-
lated genes, including the potential use of some
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latent/persistent infection, we discuss its partic-
ipation in further detail below.
4. THE dosRS REGULON IS CONSERVED
BETWEEN M. BOVIS AND MTB
The dosRS (also known as devRS) two-com-
ponent system of Mtb regulates the expression
of a set of 48 genes induced either by hypoxic
shift-down or exposure to low doses of NO
in vitro [114] and constitutes an operon with
complex regulation that participates in bacterial
response against a wide range of stresses [92].
DosR is the response regulator with DNA-bind-
ing activity, and DosS is one out of two Sensor
Histidine Kinases (HK), along with DosT,
which phosphorylates and thus regulates DosR
DNA-binding activity. Its relevance in myco-
bacteria was independently conﬁrmed by two
groups, using M. bovis var. BCG (a M. bovis
strain where a set of genomic deletions, inser-
tions, and duplications have occurred as a con-
sequence of in vitro passages) as a model
organism [10], and then conﬁrmed in Mtb
[79], where mutants lacking either one or both
components are affected in their capacity to sur-
vive a long-term culture under oxygen-limiting
conditions. On the other hand, conﬂicting
reports about its participation during infection
in animal models have been published [62,
78], perhaps attributable to the different models
used by each group. Indeed, Converse et al.
[18] analyzed the participation of the dosRS
system in four different models of Mtb infection
(rabbits, guinea pigs, mouse hollow-ﬁbre, and
mouse), and found a growth defect only in
mouse and guinea pigs. Kesavan et al. [51] ana-
lyzed expression of DosR-regulon and non-
DosR controlled genes during Mtb persistent
infection in rabbits. Another analysis of myco-
bacterial response to hypoxia and exposure to
nitric oxide, including 14 different vaccine
strains of M. bovis var. BCG, revealed the pres-
ence of a functional DosR-regulon similar to
that found in Mtb [59]. Nevertheless, several
BCG vaccine strains lacked narK2 and narX
induction and exhibit an altered phenotypes
during dormancy [46]. We should notice the
lack of immune responses to DosR regulon pro-
teins following M. bovis var. BCG subcutane-
ous vaccination in a mouse model, and even
in humans [35, 59], whereby such lack of
induction might be the consequence, at least
partially, of reduced bacterial survival with an
inadequate space-temporal antigen production
and presentation.
T h eg e n o m eo fM. bovis strain AF2122/97 is
virtually identical (99.95%) to that of Mtb
strains H37Rv or CDC1551 [34]. By in silico
analysis, comparing the predicted protein
sequences derived from the AF2122/97 and
H37Rv DosR antigens, we found an average
97% identity at the amino acid level in 41 out
of 48 proteins, with only one amino acid differ-
ence in the reported sequences of DosS, within
a predicted GAF domain. GAF presents haem-
binding activity [98]. The other HK, DosT,
already shown to phosphorylate DosR in vitro
[91] and also relevant for survival under hyp-
oxic conditions [52], also has one amino acid
difference within a GAF domain, whereas
DosR is 100% identical. This constitutes a
strong indicator of the potential capacity of
M. bovis to induce a bacterial survival mecha-
nism that would enable it to remain present in
cattle in a latent state. We can question whether
or not differences in such GAF domains, or
even in the rest of the proteins belonging to
the DosR-regulon, have a biological role in
mycobacterial adaptation to a different host.
5. CURRENT ASSAYS AND STRATEGIES
FOR IMPROVING HUMAN LATENT
TUBERCULOSIS DIAGNOSIS
For many decades, the TST assay, using a
puriﬁed protein derivative (PPD), has been the
most commonly used test to check for tubercu-
losis in cases of subclinical infection, both in
humans and in cattle, with a little variation in
the latter by comparison of reactivity toward
PPD from M. bovis versus PPD from Mycobac-
terium avium. Mycobacterial PPD, as reported
elsewhere, consists of a mixture of several hun-
dred secreted proteins, obtained by trichloroace-
tic acid precipitation of cell-free culture ﬁltrates
derived from pathogenic mycobacteria. Due to
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speculate over differences in PPD constitution
for Mtb, M. bovis and M. avium, for example,
affecting speciﬁcity of detection, although a
detailed analysis (in silico or proteomic) that
ensures such a prediction should be conducted.
The use of PPD has a major drawback, as
most antigens present in it are also present in
M.bovisvar.BCG,abacterialstrainusedtovac-
cinate humans at an early age, which may affect
the speciﬁcity of the test [6]. Despite this, TSTis
still considered the best tool for classifying indi-
viduals with no symptoms of clinical TB as
latentlyinfected[64].Paradoxically,theproteins
used as antigens in TSTare produced by myco-
bacteria under conditions not experimentally
deﬁned as persistent. In spite of this fact, their
use is considered in some developed countries
as a valuable means of diagnosing both clinical
(active) and subclinical (latent) TB [2, 6, 15]. It
was not until very recently that new tests started
to emerge for determining TB infection status
[6, 17]. These are based on the detection of
IFN-c in bloodsamples after in vitro stimulation
of blood cells with the so-called speciﬁc Mtb
antigens ESAT-6 and CFP-10 [5], which are
considered speciﬁc due to their absence in M.
bovis var. BCG used in human vaccinations.
This assay is the basis of a kit commercially
available for determining human infection
(QuantiFERON
-TB Gold; Cellestis Limited,
Carnegie, Victoria, Australia). In humans, a
study carried out in India based on measuring
the cellular response (IFN-c production) trig-
gered by ESAT-6 and CFP-10 of Mtb,i n d i c a t e d
a prevalence of 80% of latent TB infection in an
apparently healthy population used in the study
[53]. However, ESAT-6 and CFP-10 are con-
served in wild-type M. bovis, and do not allow
the determination of which pathogenic myco-
bacteria (Mtb or M. bovis) is infecting humans
unless time-consuming procedures of microbio-
logical culture, biochemical and antibiotic sus-
ceptibility tests or PCR approaches, not yet
standard in some settings, have been conducted.
In this regard, patients who had a negative
microbiological cultures and normal lung his-
tology were found to contain the insertion
sequence (IS) 6110, a characteristic region of
the tubercle bacilli, by in situ PCR [43].
On the other hand, proteins belonging to the
DosR-regulon, which are expressed under
experimental conditions considered to mimic
aspects of latency, have also been evaluated as
targets that differentiate TB infection status
[30, 35]. HspX proved to be a good stimulator
of the cellular immune response in patients with
asymptomatic tuberculosis [30, 35]thus promis-
ing to be a new, good, and speciﬁc marker for
latent TB infection that could replace the TST.
However, this protein was immunogenic for B
cells of patients with active pulmonary tubercu-
losis as well [119], and it is still unknown
whether or not HspX could indeed be a good
marker of latent TB infection at this point.
Therefore, three proteins of the DosR-regulon,
namely Rv1733c, Rv2031c (HspX), and
Rv2626c, were evaluated in an independent
study, and it was found that they induced a good
cellular immune response in a mouse model of
latency [96]. Furthermore, in asymptomatic,
TST+ individuals from the Netherlands, a coun-
try with low incidence of TB (TST+, being a
marker of latent infection),theimmune response
for four DosR-regulon proteins (Rv1733c,
Rv2029c, Rv2627c and Rv2628c) was higher
compared to that of cells from healthy people
and patients with active disease [56].
In a different context, a role for cell types
distinct to macrophages possibly linked to TB
latency has started to emerge, based on in situ
PCR evidence showing Mtb DNA in type II
pneumocytes [43] or human adipose tissue
[72]. Together, all this evidence expands alter-
natives for monitoring the infection status of
subjects suspected to contain latent mycobacte-
ria. Likewise, when bacilli are inside type II
pneumocytes, the heparin binding haemaggluti-
nin (HbhA, not part of the DosR-regulon), was
found to be strongly expressed [28, 81]. A
study measuring IFN-c production in response
to stimulation with native HbhA in 205 persons
in Belgium (a country with a low incidence of
TB where vaccination with BCG is not rou-
tinely used) gave a 92% sensitivity and a spec-
iﬁcity of 94% using HbhA, compared to 90%
and 70% obtained with PPD for detection of
infected subjects, regardless of their BCG vac-
cination status as opposed to PPD reactivity.
This indicates that in this setting, HbhA is a
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asymptomatic infection [48]. As methylation
of native HbhA is important for T-cell stimula-
tion, a recombinant protein for wide use should
possess this modiﬁcation.
Thus, published evidences suggest that
HbhA and DosR-controlled proteins might be
good candidates for discriminating between
active TB and latent infection. In fact, some
DosR-regulated antigens have been either sug-
gested or already used as new sub-unitary or
DNA vaccines [7, 60, 96]. Perhaps it is about
time to redeﬁne the gold standard for TB infec-
tion status.
6. CHALLENGES IN DEFINING
PERSISTENT BOVINE TUBERCULOSIS
In humans, active disease is clearly shown
by clinical ﬁndings such as weight loss, night
fevers, and coughing. Conversely, latent infec-
tion is demonstrated because of the reactivity
to selected mycobacterial antigens with no signs
of disease [30, 35, 53]. In cattle, there is no
clear sign of a different status of active versus
latent infection, and the concept of latent infec-
tion has remained more as a speculation than a
proven fact [14, 42, 84, 109]. Perhaps this is
inﬂuenced by the relatively short life span of
cows compared to humans, or the lack of ethi-
cal concerns about sacriﬁcing infected individu-
als, with greater concerns about economical
losses and no attention to better understanding
the infective process. However, this latter point
does not consider continued transmission to
animal and human hosts.
Latency has been suspected in animals that,
upon exposure, turn positive to TST or an
IFN-c release assay using bovine PPD,
puriﬁed ESAT-6/CFP-10 or the commercially
available kit based on IFN-c (BOVIGAM,
Prionics, Zurich, Switzerland) [1, 120] that also
uses PPD [14]. This complicates the
interpretation and diagnosis of animals truly
infected with human pathogens or environmen-
tal mycobacteria [47, 107]. In fact, PPD
induced cross-reactions that varied according
to the area, ranging from 2 to 20% [40, 41].
Evidence suggesting that diagnostic assays
(TST and IFN-c tests) can detect bTB in
cattle soon after M. bovis infection regardless
of the dose has been published [27, 70] thus,
none of the tests currently available for the
diagnosis of bTB allow a perfectly accurate
determination of the M. bovis infection status
of cattle [26]. Other authors indicate that during
cow-to-cow M. bovis transmission, it takes
about two months to present a TST+ reaction
(ranging from 8 to 65 days) [38], potentially
increasing the number of false negative results.
Moreover, reversion from a TST+ result occurs
at a 5% rate per year [38], possibly indicating
eradication of infection or simply waning of
immune memory.
As an alternative, an enhanced version of
TST, which includes determination of
MPB83-speciﬁc antibody responses, was devel-
oped and found to have a positive correlation
with bacterial loads in infected cattle [61].
Denis et al. [31] used a different strategy by
including immune modulators in an IFN-c
release assay, and found that anti-IL10 antibod-
ies increased sensitivity of detection. However,
these improvements are far from establishing
whether or not latency occurs during bovine
infection, thus further strengthening the need
of either using antigens that allow this distinc-
tion for human TB and see how do they work
in the veterinary setting, or ﬁnding new anti-
gens that help to determine the status (active
or persistent) of infection in cattle. We must
also consider that animals naturally show vari-
ability in TST responses, and some show no
clinical signs of disease or visible lesions when
slaughtered, with microbiological cultures
being negative or positive but from lymph
nodes only. Some cows have the ability to resist
overt infection despite exposure to M. bovis.
The signiﬁcant numbers of TST+ cattle that
have no evidence of infection at abattoir meat
inspections or on laboratory examinations
would support, at least in part, the idea of a
latent infection during bovine tuberculosis [84].
Although BCG has been shown to be an
effective vaccine against bTB even using a
low dose in cattle [11], it cannot be widely used
unless a cost-effective laboratory test discrimi-
nates between infected and vaccinated cattle.
IFN-c responses to PPD are induced by BCG
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duration are dose-dependent and short-lived
[4]. Some antigens are either not present (i.e.
ESAT-6 or CFP-10) or are only weakly
expressed (i.e. MPB64 or MPB70) in BCG,
and their use in the IFN-c assay has been
shown to offer an opportunity to discriminate
between animals infected with M. bovis and
those vaccinated with BCG [44, 83, 112]. Quite
interestingly, T cell-responses against ESAT-6
correlated better with disease severity in cattle
[113].
In addition to the lack of clinical symptoms,
it is known that livestock is likely to present a
TST+ reaction because of exposure to non-
pathogenic, environmental mycobacteria [47,
107], thus increasing the rates of false positive
detection. Recently, evidence of the effect of
environmental strains of M. avium interfering
with immune responses blocking BCG multipli-
cation and induction of protective immunity to
tuberculosis has been found [29, 121].
Further complications in deﬁning which ani-
mals are indeed infected (actively or persis-
tently) arise from the phenomenon of anergy.
The origins of anergy in tuberculous individuals
have not been completely deﬁned but it is
attributed to immunosuppression [55] and more
recently to an undeﬁned type of tolerance [47,
121]. In particular, in cattle under intensive pro-
duction, the cases of anergy could be related to
stressing factors such as transportation, han-
dling, metabolic unbalance, and treatments with
prostaglandins or corticosteroids, among others
[32]. A post-mortem study with healthy, TST+
animals, with no visible injuries, indicated that
the expression of interleukin IL-4 d3 in these
animals may be playing an important role in
maintaining protection against infection after
exposure to M. bovis [89, 90]. Therefore, this
cellular response could be considered a particu-
lar hallmark of latent infection in cattle, consti-
tuting a plausible biomarker from the host’s
point of view.
Clearly the existence of animals with asymp-
tomatic bTB imposes a great disadvantage to
the veterinary ﬁeld, further supporting the need
for well established testing markers to distin-
guish active versus latent infection in cattle.
These tests need to either directly measuring
gene expression from M. bovis isolated from
well-deﬁned histopathological sections, or eval-
uating cellular markers from infected animals in
low and high-incidence settings of bTB or
experimentally infected in a time-course man-
ner as already started by Thacker et al. [106].
Similar to latent tuberculosis in humans, in cat-
tle, latency represents a signiﬁcant challenge for
the eradication of bTB, through the possible
reactivation in an infected animal [14]. Despite
the current progress achieved in the study of
latent tuberculosis in humans, deﬁning latency
in bTB has practically and inexplicably been
ignored, except for a recent call to deﬁne the
participation of latency in the control of bTB
[42]. It is tempting to envision that cattle may
be the species in which persistent infection bet-
ter resembles human latency. However, meth-
ods for experimental induction of persistent
tuberculosis in cattle do not exist yet [109].
7. CONCLUDING REMARKS
AND FUTURE DIRECTIONS
Latent tuberculosis infection remains a pub-
lic health problem, because reactivation can
happen many years after primary infection
resulting in renovated transmission of strains
previously thought to have been gotten rid of,
or that existed thoroughly unsuspected. Despite
latent TB being recognized in humans for a
long time, persistent infection in cattle has lar-
gely been ignored. A comparative genomics
point of view could be quintessential in provid-
ing better means to control, diminish or eradi-
cate epidemiologically relevant events. It
would be very interesting to investigate whether
monitoring expression of genes belonging to
the DosR-regulon in M. bovis-infected cattle
would ﬁnally allow a description of a latent/per-
sistent phase of bTB. Using this approach in
combination with analysis of the expression
and role of mycobacterial genes required for
active growth would allow a more precise def-
inition of temporal proﬁles during transition
stages of the infection. One of the most active
lines of basic research in the ﬁeld of tuberculo-
sis consists of deciphering what genes are
turned on or off when mycobacteria move from
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persistence.
Deﬁning whether latency occurs in cattle
and assessing the potential participation of dif-
ferent cell types as ‘‘incubators’’ of persistent
bacilli can lay the groundwork for identifying
genes and/or proteins that may be useful both
for diagnosis and for the development of new
vaccines against human and bovine tuberculo-
sis. Alternatively, infected organs, from well
characterized stages of infection in cattle are
highly abundant in endemic areas and constitute
an excellent source for which gene-speciﬁc or
genome-wide expression proﬁles using ultra-
sensitive real time reverse transcription and
quantitative PCR can be used to monitor the
expression of genes required for active or latent
infection based on Mtb studies, allowing dissec-
tion of their participation in a natural setting.
Due to their relevance for humans, studies of
latency/persistence or isolated factors linked to
it (i.e. hypoxia) have solely been studied in
two slow-growing mycobacteria (Mtb and
M. bovis var. BCG), but it might well be that
other organisms within this genus are able to
sustain such an infection, either in humans or
their natural/preferred hosts. It would be inter-
esting to look at different organs in chronically
infected organisms, and perhaps conduct a spe-
cies-wide analysis of the microbes found there,
using markers such as ribosomal genes for
example, or those that better and more accu-
rately show the population represented in those
environments.
On the other hand, addressing immune pro-
ﬁles or host susceptibility factors, either in
experimentally- or naturally-infected cattle,
would be a way to start unravelling the partici-
pation and balance between bacteria and bovine
host immune system, whereby a persistent state
and its contribution to continued transmission
during long periods of time despite lack of evi-
dence of ill animals could be ascertained. Thus,
detailed histopathological or even molecular
analyses are required to discern how many
bTB lesions harbour mycobacteria in an active
and/or persistent/latent state. Further experi-
ments linking immunological proﬁles to the
presence of mycobacteria in the different types
of lesions, with demonstration of bacterial
expression of latency markers are required.
An immune response proﬁle assessed in cows
with diverse degrees of pathology, which corre-
lates with contained infections of minimal tis-
sue damage, might indicate which host factors
are important for maintaining a persistent,
non-progressive infection.
Considering the rapid accumulation and
availability of genome sequences, we could
use this information to answer whether there
is any biological meaning to possible changes
in DosRS sequences of vaccine and mycobacte-
rial strains, and their likely impact on efﬁcacy
of protection and virulence, respectively. Given
the variety of insertion, deletion and duplication
events that occurred in BCG strains, the differ-
ences found in DosS and DosT, key compo-
nents of a system developed to sense and
respond to oxygen limitations or immune
response-derived stressors, might have an
impact in how mycobacteria adapts to its host.
Mapping of DosRS and DosT sequences in dif-
ferent environmental pathogenic strains of M.
bovis, for example, should be undertaken to
assess genetic variability in these genes. Moni-
toring expression of these genes in the same
isolates and/or infected tissues would reveal sig-
niﬁcant information about latency in cattle. We
must consider that it is very likely that genes
required for dormancy in Mtb which have a
very close homolog in M. bovis, might be
expressed in vivo during bTB.
The participation of genes other than the
DosR-regulated ones cannot be ruled out, but
their participation and relevance need to be fur-
ther studied and validated in infected subjects.
Studies showing the presence of humans
latently infected with M. bovis indicate this bac-
terium may be able to persist in such a form in a
non-preferred host, thus strengthening the
notion of a possible persistent form in its natural
host, the bovine, where it may also be latently
harboured. Furthermore, Mtb has been isolated
from asymptomatic cattle, suggesting the same
capability of this bacterium to cause a silent
infection in these animals. On the other hand,
as no clinical symptoms are developed in
infected bovines, this imposes a harder chal-
lenge for trying to establish evidence of latent/
persistent infection in cows. The occasional
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to TSTassays in cows, constitutes by no means
a way to determine if M. bovis lies dormant in
cattle and what the impact of such a state may
have on the continued transmission of bTB.
This clearly indicates that we need to focus
our attention on its close relative and use the
knowledge gathered there to speed up advances
for the veterinary ﬁeld dealing with tuberculosis
every day.
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